Breast Cancer Clinical Trial
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer
Summary
This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination.
The iBreastExam is a handheld device that performs a painless electronic palpation (examination by touch) of the breast. The device is designed to detect breast abnormalities that may require breast imaging and additional clinical examination by a nurse or doctor. The iBreastExam device creates a color map of the breast, with red spots indicating areas that may be abnormal.
Eligibility Criteria
Inclusion Criteria:
Female patient
Over 18 years of age, able to consent
RLC patients presenting to RLC or BAIC for mammogram and CBE
Asymptomatic and symptomatic patients will be included
Exclusion Criteria:
Male patients
Patients under 18 years of age, unable to consent
Pregnant patients
Lactating patients
Non-intact skin
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 2 Locations for this study
New York New York, 10035, United States
New York New York, 10065, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.